Morgan Stanley Issues Positive Forecast for Agilent Technologies (NYSE:A) Stock Price

Key Points

• Morgan Stanley raised Agilent Technologies’ price target from $160 to $175 and maintained an “overweight” rating, implying 17.52% potential upside from the prior close.
• Agilent reported quarterly EPS of $1.49, above the $1.41 consensus estimate, while revenue rose 10% year over year to $1.83 billion. Analysts expect full-year EPS of approximately $6.01.
• The stock traded at $148.91, with a consensus analyst rating of “Moderate Buy” and an average price target of $160.24; institutional investors own 87.41% of outstanding shares.

Agilent Technologies (NYSE:A - Get Free Report) had its price target lifted by investment analysts at Morgan Stanley from $160.00 to $175.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an "overweight" rating on the medical research company's stock. Morgan Stanley's price target would suggest a potential upside of 17.52% from the company's previous close.

A has been the topic of a number of other research reports. Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a report on Friday, June 26th. They set an "outperform" rating and a $155.00 price objective on the stock. TD Cowen increased their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a "buy" rating in a report on Thursday, May 28th. HSBC reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research report on Wednesday, June 3rd. Wells Fargo & Company lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Thursday, May 28th. Finally, Wolfe Research reaffirmed a "hold" rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Price Performance

NYSE:A traded down $0.58 during trading hours on Wednesday, hitting $148.91. The company's stock had a trading volume of 289,723 shares, compared to its average volume of 2,224,047. The business's 50-day moving average is $134.70 and its two-hundred day moving average is $125.23. The company has a market capitalization of $42.06 billion, a PE ratio of 29.90, a PEG ratio of 2.64 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies has a 52-week low of $108.35 and a 52-week high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the firm earned $1.31 EPS. The business's revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts anticipate that Agilent Technologies will post 6.01 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of A. Core Wealth Advisors LLC purchased a new position in Agilent Technologies during the fourth quarter worth $26,000. SHP Wealth Management purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at $26,000. Navalign LLC purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at $27,000. Cedar Mountain Advisors LLC acquired a new stake in shares of Agilent Technologies during the first quarter valued at $27,000. Finally, MV Capital Management Inc. purchased a new stake in Agilent Technologies during the 4th quarter worth about $28,000. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source